Diabetes is the single leading cause of kidney failure in the U.S., accounting for about 44 percent of the people who start treatment for kidney failure each year. To help raise awareness of the links between diabetes and chronic kidney disease (CKD), Fresenius Medical Care North America (FMCNA), the nation’s leading network of dialysis facilities, will be a speaker sponsor at the American Diabetes Association (the Association) EXPO Pittsburgh, to be held at the David L. Lawrence Convention Center, on Saturday, Nov. 5, from 9:00 a.m. – 4:00 p.m.

More than 4,000 attendees are expected to attend the free EXPO event, which includes health screenings, cooking demonstrations, product and service exhibitors, along with leading experts talking about diabetes management and prevention. FMCNA will host an exhibit at Booth 519, and will also sponsor multiple presentations of " Chronic Kidney Disease: Are You at Risk?” in the booth classroom space.

This seminar will include an overview of FMCNA's Treatment Options Program (TOPs) education sessions, which are held across the U.S. for people at risk for CKD. Anyone with a family history of kidney disease or other risk factors, such as diabetes or high blood pressure, is encouraged to attend. The sessions provide information about CKD management and the treatments available when it leads to kidney failure. Attendees will have the opportunity to register for a TOPs class offered near them.

"There is a strong correlation between diabetes and kidney disease, so people need to understand the symptoms and risk factors associated with CKD," said Laura Conaway, regional vice president, Fresenius Medical Care. "If you have diabetes or high blood pressure, it's especially important to get regular screenings and be more aware of your overall health."

CKD disproportionately affects African-Americans, Hispanics, Asians, American Indians and senior citizens, and being overweight also increases the chances of developing CKD. There is an association because these groups are at higher risk for diabetes and high blood pressure.

If you liked this article you might like

Mining and Resources Lead Europe's Benchmarks Lower

European Stocks Diverge as Investors Weigh Economic Optimism With Mixed Earnings

Wednesday's Earnings Push Stocks Lower as Mood Sours in Europe

Here's What's Boosting European Benchmarks

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space